Exact Mass: 243.1947

Exact Mass Matches: 243.1947

Found 273 metabolites which its exact mass value is equals to given mass value 243.1947, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Phencyclidine

1-(1-Phenylcyclohexyl)piperidine

C17H25N (243.1987)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D004791 - Enzyme Inhibitors

   

3-Hydroxy-N-(2-oxotetrahydrofuran-3-yl)octanamide

3-Hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide

C12H21NO4 (243.1471)


   

NA 16:6

2,4-Hexadienamide, N-(2-methylpropyl)-6-phenyl-, (E,E)-

C16H21NO (243.1623)


   

2-heptylquinolin-4(1H)-one

2-heptylquinolin-4(1H)-one

C16H21NO (243.1623)


   

N-Undecanoylglycine

2-Undecanamidoacetic acid

C13H25NO3 (243.1834)


N-Undecanoylglycine is an acylglycine with C-11 fatty acid group as the acyl moiety. Acylglycines 1 possess a common amidoacetic acid moiety and are normally minor metabolites of fatty acids. Elevated levels of certain acylglycines appear in the urine and blood of patients with various fatty acid oxidation disorders. They are normally produced through the action of glycine N-acyltransferase which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine ↔ CoA + N-acylglycine. N-Undecanoylglycine is an acylglycine with C-11 fatty acid group as the acyl moiety.

   

Chalciporone

(6E,8Z)-9-(7-methyl-3H-azepin-2-yl)nona-6,8-dien-3-one

C16H21NO (243.1623)


7-Methyl-2-(7-oxo-1,3-nonadienyl)-3H-azepine is found in mushrooms. 7-Methyl-2-(7-oxo-1,3-nonadienyl)-3H-azepine is a constituent of the toxic mushroom Chalciporus piperatus. Pungent principle from fruit-bodies of the toxic mushroom Chalciporus piperatus. Chalciporone is found in mushrooms.

   

Prolyl-Lysine

6-Amino-2-{[hydroxy(pyrrolidin-2-yl)methylidene]amino}hexanoate

C11H21N3O3 (243.1583)


Prolyl-Lysine is a dipeptide composed of proline and lysine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

Tiglylcarnitine

(3R)-3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


Tiglylcarnitine is an acylcarnitine. More specifically, it is an tiglic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805, PMID: 14518824, PMID: 3435793), and ECHS1 deficiency (PMID: 31908952). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937), carcinoma, lewis lung (PMID: 30839735), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945). Tiglylcarnitine is also detected in the urinary organic acid and blood spot acylcarnitine profiles in patients with mitochondrial acetoacetyl-CoA thiolase (T2) deficiency, an inborn error of metabolism affecting isoleucine and ketone bodies in the catabolic process (PMID: 14518824 ). Tiglylcarnitine is found to be associated with celiac disease, which is also an inborn error of metabolism. Tiglylcarnitine has been identified in the human placenta (PMID: 32033212 ). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews]. Tiglylcarnitine is detected in the urinary organic acid and blood spot acylcarnitine profiles in patients with

   

Lysylproline

(2S)-1-[(2S)-2,6-diaminohexanoyl]pyrrolidine-2-carboxylic acid

C11H21N3O3 (243.1583)


Lysylproline is a dipeptide composed of lysine and proline. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

N5-Hexanoylspermidine

N-(4-aminobutyl)-N-(3-aminopropyl)hexanamide

C13H29N3O (243.2311)


N5-Hexanoylspermidine is found in pulses. N5-Hexanoylspermidine is an alkaloid from senescing ovaries of pea (Pisum sativum Alkaloid from senescing ovaries of pea (Pisum sativum). N5-Hexanoylspermidine is found in pulses and common pea.

   

2-Ethylacryloylcarnitine

3-[(2-methylidenebutanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


2-Ethylacryloylcarnitine is an acylcarnitine. More specifically, it is an ethacrylic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Ethylacryloylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 2-Ethylacryloylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Tiglylcarnitine

3-(pent-4-enoyloxy)-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


4-Tiglylcarnitine is an acylcarnitine. More specifically, it is an pent-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 4-Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular 4-Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805, PMID: 14518824, PMID: 3435793), and ECHS1 deficiency (PMID: 31908952). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937), carcinoma, lewis lung (PMID: 30839735), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(3E)-Tiglylcarnitine

3-(pent-3-enoyloxy)-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


(3E)-Tiglylcarnitine is an acylcarnitine. More specifically, it is an (3E)-pent-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3E)-Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine (3E)-Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular (3E)-Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805, PMID: 14518824, PMID: 3435793), and ECHS1 deficiency (PMID: 31908952). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937), carcinoma, lewis lung (PMID: 30839735), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Tiglylcarnitine

3-(pent-2-enoyloxy)-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


2-Tiglylcarnitine is an acylcarnitine. More specifically, it is an pent-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Tiglylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 2-Tiglylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. In particular 2-Tiglylcarnitine is elevated in the blood or plasma of individuals with beta ketothiolase deficiency/acat1 gene mutation (PMID: 27264805, PMID: 14518824, PMID: 3435793), and ECHS1 deficiency (PMID: 31908952). It is also decreased in the blood or plasma of individuals with familial mediterranean fever (PMID: 29900937), carcinoma, lewis lung (PMID: 30839735), metabolic syndrome, type 2 diabetes mellitus, and cardiovascular diseases (PMID: 24710945). Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Methylbut-2-enoylcarnitine

3-[(3-methylbut-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


3-methylbut-2-enoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylbut-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-methylbut-2-enoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 3-methylbut-2-enoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

N-((1R,2S,4S)-Bicyclo[2.2.1]heptan-2-yl)-9-methyl-9H-purin-6-amine

N-((1R,2S,4S)-Bicyclo[2.2.1]heptan-2-yl)-9-methyl-9H-purin-6-amine

C13H17N5 (243.1484)


   

hydroxymorphinan

17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-trien-6-ol

C16H21NO (243.1623)


   

3-Hydroxymorphinan

17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2,4,6-trien-4-ol

C16H21NO (243.1623)


   

6H-Dibenzo[a,g]quinolizin-3-ol,5,8,13,13a-tetrahydro-2,9,10-trimethoxy-

6H-Dibenzo[a,g]quinolizin-3-ol,5,8,13,13a-tetrahydro-2,9,10-trimethoxy-

C14H29NO2 (243.2198)


   

(+)-Dienomycin C

(+)-Dienomycin C

C16H21NO (243.1623)


   

2-Heptyl-4-hydroxy quinoline

2-Heptyl-4-hydroxy quinoline

C16H21NO (243.1623)


   

2-Heptyl-4-hydroxyquinoline

2-Heptyl-4-hydroxyquinoline

C16H21NO (243.1623)


A monohydroxyquinoline that is 4-hydroxyquinoline bearing an additional heptyl substituent at position 2.

   

Maybridge4_003372

Maybridge4_003372

C17H25N (243.1987)


   

MCULE-4201437053

MCULE-4201437053

C12H21NO4 (243.1471)


   

N-lauroylethanolamine

N-(2-HYDROXYETHYL)DODECANAMIDE

C14H29NO2 (243.2198)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2

   

Tetradecasphing-4-enine

Tetradecasphing-4-enine

C14H29NO2 (243.2198)


   

14-aminotetradecanoic Acid

14-aminotetradecanoic Acid

C14H29NO2 (243.2198)


   

chalciporone

(6E,8Z)-9-(7-methyl-3H-azepin-2-yl)nona-6,8-dien-3-one

C16H21NO (243.1623)


   

(2E,4E)-N-isobutyldodeca-2,4-dien-8,10-diynamide|2-Methylpropylamide-(2E,4E)-2,4-Dodecadiene-8,10-diynoic acid|Anacydin|dodeca-2E,4E-diene-8,10-diynoic acid isobutylamide|Dodecadien-(2trans.4trans)-diin-(8.10)-saeure-(1)-isobutylamid

(2E,4E)-N-isobutyldodeca-2,4-dien-8,10-diynamide|2-Methylpropylamide-(2E,4E)-2,4-Dodecadiene-8,10-diynoic acid|Anacydin|dodeca-2E,4E-diene-8,10-diynoic acid isobutylamide|Dodecadien-(2trans.4trans)-diin-(8.10)-saeure-(1)-isobutylamid

C16H21NO (243.1623)


   

3-(2-methylbutyryloxy)tropan-6,7-diol

3-(2-methylbutyryloxy)tropan-6,7-diol

C12H21NO4 (243.1471)


   

4-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)butan-1-amine

4-(2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indol-1-yl)butan-1-amine

C15H21N3 (243.1735)


   

2,4-Undecadiene-8,10-diynoic acid isopentylamide

2,4-Undecadiene-8,10-diynoic acid isopentylamide

C16H21NO (243.1623)


   

Mantella Alkaloid 243D

Mantella Alkaloid 243D

C17H25N (243.1987)


   

plantagoamidinic acid B

plantagoamidinic acid B

C11H21N3O3 (243.1583)


   

1,1-(1-methyl-piperidine-2,6-diyl)-bis-butan-2-ol|2,6-Bis-(2-hydroxy-butyl)-1-methyl-piperidin|2,6-bis-(2-hydroxy-butyl)-1-methyl-piperidine

1,1-(1-methyl-piperidine-2,6-diyl)-bis-butan-2-ol|2,6-Bis-(2-hydroxy-butyl)-1-methyl-piperidin|2,6-bis-(2-hydroxy-butyl)-1-methyl-piperidine

C14H29NO2 (243.2198)


   

2-allyl-5-(pent-2-en-4-ynyl)-cis-decahydroquinoline

2-allyl-5-(pent-2-en-4-ynyl)-cis-decahydroquinoline

C17H25N (243.1987)


   

N-(2-methylbutyl)undeca-2E,4Z-diene-8,10-diynamide|undeca-2E,4Z-dien-8,10-diynoic acid 2-methylbutylamide|undeca-2E,4Z-diene-8,10-diynoic acid 2-methylbutylamide|undeca-2E,4Z-diene-8,10-diynoic acid-2-methylbutylamide

N-(2-methylbutyl)undeca-2E,4Z-diene-8,10-diynamide|undeca-2E,4Z-dien-8,10-diynoic acid 2-methylbutylamide|undeca-2E,4Z-diene-8,10-diynoic acid 2-methylbutylamide|undeca-2E,4Z-diene-8,10-diynoic acid-2-methylbutylamide

C16H21NO (243.1623)


   

octa-2Z,4E-dienoic acid 2-phenylethylamide

octa-2Z,4E-dienoic acid 2-phenylethylamide

C16H21NO (243.1623)


   

CHEMBL522984

CHEMBL522984

C15H21N3 (243.1735)


   

(+)-clavaminol C|(2R,3S)-2-acetylaminododecan-3-ol|clavaminol C

(+)-clavaminol C|(2R,3S)-2-acetylaminododecan-3-ol|clavaminol C

C14H29NO2 (243.2198)


   

N-(10-hydroxy-10-methylundecyl)acetamide

NCGC00385670-01!N-(10-hydroxy-10-methylundecyl)acetamide

C14H29NO2 (243.2198)


   

8-acetamido-2-methyl-7-oxononanoic acid

NCGC00380389-01!8-acetamido-2-methyl-7-oxononanoic acid

C12H21NO4 (243.1471)


   

8-acetamido-2-methyl-7-oxononanoic acid

8-acetamido-2-methyl-7-oxononanoic acid

C12H21NO4 (243.1471)


   

PHENCYCLIDINE

PHENCYCLIDINE

C17H25N (243.1987)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D006213 - Hallucinogens C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent D004791 - Enzyme Inhibitors

   

3-hydroxy-C8-homoserine lactone

3-Hydroxy-N-(2-oxotetrahydrofuran-3-yl)octanamide

C12H21NO4 (243.1471)


CONFIDENCE standard compound; INTERNAL_ID 215

   

HHQ

HHQ aka 2-heptylquinolin-4(1H)-one

C16H21NO (243.1623)


   

3-Hydroxymorphinan

3-Hydroxymorphinan

C16H21NO (243.1623)


   
   
   

(2R,5S)-2-allyl-5-((E)-pent-2-en-4-yn-1-yl)decahydroquinoline

(2R,5S)-2-allyl-5-((E)-pent-2-en-4-yn-1-yl)decahydroquinoline

C17H25N (243.1987)


   

(2R,5R)-2-allyl-5-((E)-pent-2-en-4-yn-1-yl)decahydroquinoline

(2R,5R)-2-allyl-5-((E)-pent-2-en-4-yn-1-yl)decahydroquinoline

C17H25N (243.1987)


   

(2R,5S,8aS)-2-allyl-5-((E)-pent-2-en-4-yn-1-yl)decahydroquinoline

(2R,5S,8aS)-2-allyl-5-((E)-pent-2-en-4-yn-1-yl)decahydroquinoline

C17H25N (243.1987)


   

(5S,8R)-8-(but-3-en-1-yl)-5-((E)-pent-2-en-4-yn-1-yl)octahydroindolizine

(5S,8R)-8-(but-3-en-1-yl)-5-((E)-pent-2-en-4-yn-1-yl)octahydroindolizine

C17H25N (243.1987)


   

(5S,8R)-8-ethyl-5-((1E,4E)-hepta-1,4-dien-6-yn-1-yl)octahydroindolizine

(5S,8R)-8-ethyl-5-((1E,4E)-hepta-1,4-dien-6-yn-1-yl)octahydroindolizine

C17H25N (243.1987)


   

8-ethyl-5-(hept-4-en-6-yn-1-yl)-1,2,3,5,8,8a-hexahydroindolizine

8-ethyl-5-(hept-4-en-6-yn-1-yl)-1,2,3,5,8,8a-hexahydroindolizine

C17H25N (243.1987)


   

1-((4-amino-2-propylpyrimidin-5-yl)methyl)-2-methylpyridinium

1-((4-amino-2-propylpyrimidin-5-yl)methyl)-2-methylpyridinium

C13H17N5 (243.1484)


   

Lauroyl-EA

N-(Dodecanoyl)-ethanolamine

C14H29NO2 (243.2198)


   

tetradecasphing-4E-enine

tetradecasphing-4E-enine

C14H29NO2 (243.2198)


   

2-ethylacrylylcarnitine

2-ethylacrylylcarnitine

C12H21NO4 (243.1471)


   

2-amino-tetradecanoic acid

2-amino-tetradecanoic acid

C14H29NO2 (243.2198)


   

Lys-pro

6-amino-2-(pyrrolidin-2-ylformamido)hexanoic acid

C11H21N3O3 (243.1583)


A dipeptide formed from L-lysine and L-proline residues.

   

Pro-lys

1-(2,6-diaminohexanoyl)pyrrolidine-2-carboxylic acid

C11H21N3O3 (243.1583)


A dipeptide formed from L-proline and L-lysine residues.

   

N5-Hexanoylspermidine

N-(4-aminobutyl)-N-(3-aminopropyl)hexanamide

C13H29N3O (243.2311)


   

CAR 5:1

3-{[(2E)-2-methylbut-2-enoyl]oxy}-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


   

3OH-C8-HSL

N-(3-hydroxy-octanoyl)-homoserine lactone

C12H21NO4 (243.1471)


   

Lauroyl-ethanolamine

N-(Dodecanoyl)-ethanolamine

C14H29NO2 (243.2198)


   

C14 sphingosine

tetradecasphing-4E-enine

C14H29NO2 (243.2198)


   

1-O-tert-butyl 3-O-methyl (3R)-piperidine-1,3-dicarboxylate

1-O-tert-butyl 3-O-methyl (3R)-piperidine-1,3-dicarboxylate

C12H21NO4 (243.1471)


   

2s,3s-1-boc-2-methyl-piperidine-3-carboxylic acid

2s,3s-1-boc-2-methyl-piperidine-3-carboxylic acid

C12H21NO4 (243.1471)


   

1-(tert-butoxycarbonyl)azepane-4-carboxylic acid

1-(tert-butoxycarbonyl)azepane-4-carboxylic acid

C12H21NO4 (243.1471)


   

1-(tert-butoxycarbonyl)-3-methylpiperidine-3-carboxylic acid

1-(tert-butoxycarbonyl)-3-methylpiperidine-3-carboxylic acid

C12H21NO4 (243.1471)


   

(1-Boc-Piperidine-3yl)aceticacid

(1-Boc-Piperidine-3yl)aceticacid

C12H21NO4 (243.1471)


   

TERT-BUTYL 2-(TRIMETHYLSILYL)PYRROLIDINE-1-CARBOXYLATE

TERT-BUTYL 2-(TRIMETHYLSILYL)PYRROLIDINE-1-CARBOXYLATE

C12H25NO2Si (243.1654)


   

1-tert-Butyl 2-methyl 2-methylpyrrolidine-1,2-dicarboxylate

1-tert-Butyl 2-methyl 2-methylpyrrolidine-1,2-dicarboxylate

C12H21NO4 (243.1471)


   

2s,3r-1-boc-2-methyl-piperidine-3-carboxylic acid

2s,3r-1-boc-2-methyl-piperidine-3-carboxylic acid

C12H21NO4 (243.1471)


   

1-[(2-phenyltriazol-4-yl)methyl]piperazine

1-[(2-phenyltriazol-4-yl)methyl]piperazine

C13H17N5 (243.1484)


   

tert-butyl 4-amino-4-carbamoylpiperidine-1-carboxylate

tert-butyl 4-amino-4-carbamoylpiperidine-1-carboxylate

C11H21N3O3 (243.1583)


   

(4S,6R)-6-BENZYLOXYMETHYL-4-METHYL-4-VINYL-TETRAHYDRO-PYRAN-2-ONE

(4S,6R)-6-BENZYLOXYMETHYL-4-METHYL-4-VINYL-TETRAHYDRO-PYRAN-2-ONE

C16H21NO (243.1623)


   

1-(1H-INDOLE-3-YL)-2-PYRROLIDIN-1-YL-ETHYL]-METHYL-AMINE

1-(1H-INDOLE-3-YL)-2-PYRROLIDIN-1-YL-ETHYL]-METHYL-AMINE

C15H21N3 (243.1735)


   

tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate

tert-Butyl 4-acetyl-2,2-dimethyloxazolidine-3-carboxylate

C12H21NO4 (243.1471)


   

1-(3-METHOXYPHENYL)CYCLOPROPANECARBONITRILE

1-(3-METHOXYPHENYL)CYCLOPROPANECARBONITRILE

C14H26ClN (243.1754)


   

1-Boc-2-Methylpipecolinic acid

1-Boc-2-Methylpipecolinic acid

C12H21NO4 (243.1471)


   

n-boc-d-cyclohexylglycinol

n-boc-d-cyclohexylglycinol

C13H25NO3 (243.1834)


   

TERT-BUTYL 3-(HYDRAZINECARBONYL)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL 3-(HYDRAZINECARBONYL)PIPERIDINE-1-CARBOXYLATE

C11H21N3O3 (243.1583)


   

3-[2[[(1,1-DIMETHYLETHYL)DIMETHYL SILYL]OXY]ETHYL]-PIPERIDINE

3-[2[[(1,1-DIMETHYLETHYL)DIMETHYL SILYL]OXY]ETHYL]-PIPERIDINE

C13H29NOSi (243.2018)


   

2-aminopropan-1-ol,propane-1,2-diol,propane-1,2,3-triol

2-aminopropan-1-ol,propane-1,2-diol,propane-1,2,3-triol

C9H25NO6 (243.1682)


   

(S)-di-tert-butyl aziridine-1,2-dicarboxylate

(S)-di-tert-butyl aziridine-1,2-dicarboxylate

C12H21NO4 (243.1471)


   

Glycine, N-dodecyl-

Glycine, N-dodecyl-

C14H29NO2 (243.2198)


   

Cyclopentaneacetic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]- (9CI)

Cyclopentaneacetic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]- (9CI)

C12H21NO4 (243.1471)


   

1-BOC-3-(2-DIMETHYLAMINO-ETHYLAMINO)-AZETIDINE

1-BOC-3-(2-DIMETHYLAMINO-ETHYLAMINO)-AZETIDINE

C12H25N3O2 (243.1947)


   

3-(Boc-amino)cyclohexanecarboxylic acid

3-(Boc-amino)cyclohexanecarboxylic acid

C12H21NO4 (243.1471)


   

1-BOC-4-ETHYL-4-(HYDROXYMETHYL)-PIPERIDINE

1-BOC-4-ETHYL-4-(HYDROXYMETHYL)-PIPERIDINE

C13H25NO3 (243.1834)


   

3-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-2-carboxylic acid

3-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]piperidine-2-carboxylic acid

C12H21NO4 (243.1471)


   

1-Octyl-2-methylindole

1-Octyl-2-methylindole

C17H25N (243.1987)


   

Methyl N-Boc-piperidine-3-carboxylate

Methyl N-Boc-piperidine-3-carboxylate

C12H21NO4 (243.1471)


   

1-BOC-ISONIPECOTIC ACID HYDRAZIDE

1-BOC-ISONIPECOTIC ACID HYDRAZIDE

C11H21N3O3 (243.1583)


   

1-Boc-4-methylpiperidine-4-carboxylic acid

1-Boc-4-methylpiperidine-4-carboxylic acid

C12H21NO4 (243.1471)


   

(1S,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXANECARBOXYLIC ACID

(1S,3R)-3-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXANECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

N-BOC-3-METHYL-4-PIPERIDINECARBOXYLIC ACID

N-BOC-3-METHYL-4-PIPERIDINECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

Ethyl (R)-1-Boc-3-pyrrolidinecarboxylate

Ethyl (R)-1-Boc-3-pyrrolidinecarboxylate

C12H21NO4 (243.1471)


   

1-Boc-Nipecotic Acid Hydrazide

1-Boc-Nipecotic Acid Hydrazide

C11H21N3O3 (243.1583)


   

1-Tert-Butoxycarbonylamino-Cyclohexanecarboxylic Acid

1-Tert-Butoxycarbonylamino-Cyclohexanecarboxylic Acid

C12H21NO4 (243.1471)


   

trans-4-(Boc-Amino)cyclohexanecarboxylic acid

trans-4-(Boc-Amino)cyclohexanecarboxylic acid

C12H21NO4 (243.1471)


   

(R)-TERT-BUTYL 2,2-DIMETHYL-4-(2-OXOETHYL)OXAZOLIDINE-3-CARBOXYLATE

(R)-TERT-BUTYL 2,2-DIMETHYL-4-(2-OXOETHYL)OXAZOLIDINE-3-CARBOXYLATE

C12H21NO4 (243.1471)


   

Azepane-1,3-dicarboxylic acid 1-tert-butyl ester

Azepane-1,3-dicarboxylic acid 1-tert-butyl ester

C12H21NO4 (243.1471)


   

1-(2-METHYL-1H-PYRROL-3-YL)-ETHANONE

1-(2-METHYL-1H-PYRROL-3-YL)-ETHANONE

C14H26ClN (243.1754)


   

(3-PIPERAZIN-1-YL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER

(3-PIPERAZIN-1-YL-PROPYL)-CARBAMIC ACID TERT-BUTYL ESTER

C12H25N3O2 (243.1947)


   

(S)-1-(tert-Butoxycarbonyl)-4,4-dimethylpyrrolidine-2-carboxylic acid

(S)-1-(tert-Butoxycarbonyl)-4,4-dimethylpyrrolidine-2-carboxylic acid

C12H21NO4 (243.1471)


   

Boc-2-Amino-1-cyclohexanecarboxylic acid

Boc-2-Amino-1-cyclohexanecarboxylic acid

C12H21NO4 (243.1471)


   

1-[2-(1H-Indol-3-yl)-ethyl]-5-oxo-pyrrolidine-3-carboxylicacid

1-[2-(1H-Indol-3-yl)-ethyl]-5-oxo-pyrrolidine-3-carboxylicacid

C15H21N3 (243.1735)


   

(1r,2s)-2-(isopropylamino)-1,2-diphenylethanol

(1r,2s)-2-(isopropylamino)-1,2-diphenylethanol

C12H21NO4 (243.1471)


   

(1S,2S)-1-AMINO-2,3-DIHYDRO-1H-INDEN-2-OL

(1S,2S)-1-AMINO-2,3-DIHYDRO-1H-INDEN-2-OL

C12H21NO4 (243.1471)


   

boc-1,2-cis-achc-oh

boc-1,2-cis-achc-oh

C12H21NO4 (243.1471)


   

(1R,2R)-Boc-aminocyclohexane carboxylic acid

(1R,2R)-Boc-aminocyclohexane carboxylic acid

C12H21NO4 (243.1471)


   

tert-butyl 3-(2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate

tert-butyl 3-(2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate

C12H21NO4 (243.1471)


   

N-(tert-Butoxycarbonyl)-N-cyclopentylglycine

N-(tert-Butoxycarbonyl)-N-cyclopentylglycine

C12H21NO4 (243.1471)


   

(S)-2-CHLORO-1-(3,4-DICHLOROPHENYL)ETHANOL

(S)-2-CHLORO-1-(3,4-DICHLOROPHENYL)ETHANOL

C12H21NO4 (243.1471)


   

(3R,4R)-1-[(tert-butoxy)carbonyl]-4-ethylpyrrolidine-3-carboxyli

(3R,4R)-1-[(tert-butoxy)carbonyl]-4-ethylpyrrolidine-3-carboxyli

C12H21NO4 (243.1471)


   

Ethyl N-Boc-piperidine-4-carboxylate

Ethyl N-Boc-piperidine-4-carboxylate

C12H21NO4 (243.1471)


   

boc-dl-proline ethyl ester

boc-dl-proline ethyl ester

C12H21NO4 (243.1471)


   

(R)-1-BOC-2-PIPERIDINEACETIC ACID

(R)-1-BOC-2-PIPERIDINEACETIC ACID

C12H21NO4 (243.1471)


   

tert-butyl 4-(2-methoxyethyl)piperidine-1-carboxylate

tert-butyl 4-(2-methoxyethyl)piperidine-1-carboxylate

C13H25NO3 (243.1834)


   

trans-1-(Boc-amino)-4-(2-hydroxyethyl)cyclohexane

trans-1-(Boc-amino)-4-(2-hydroxyethyl)cyclohexane

C13H25NO3 (243.1834)


   

(R)-2-(1-(tert-Butoxycarbonyl)piperidin-3-yl)acetic acid

(R)-2-(1-(tert-Butoxycarbonyl)piperidin-3-yl)acetic acid

C12H21NO4 (243.1471)


   

TERT-BUTYL 3-(N-HYDROXYCARBAMIMIDOYL)PIPERIDINE-1-CARBOXYLATE

TERT-BUTYL 3-(N-HYDROXYCARBAMIMIDOYL)PIPERIDINE-1-CARBOXYLATE

C11H21N3O3 (243.1583)


   

1-(TERT-BUTOXYCARBONYL)-4-METHYLPIPERIDINE-3-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-4-METHYLPIPERIDINE-3-CARBOXYLIC ACID

C12H21NO4 (243.1471)


   

2-{[(tert-butoxy)carbonyl]amino}-3-cyclobutylpropanoic acid

2-{[(tert-butoxy)carbonyl]amino}-3-cyclobutylpropanoic acid

C12H21NO4 (243.1471)


   

Boc-Cis-1,4-ACHC-OH

Boc-Cis-1,4-ACHC-OH

C12H21NO4 (243.1471)


   

N-(1-Methylethyl)-3-(1-Naphthalenyloxy)-1-Propanamine

N-(1-Methylethyl)-3-(1-Naphthalenyloxy)-1-Propanamine

C16H21NO (243.1623)


   

tert-butyl N-[2-oxo-2-(piperazin-1-yl)ethyl]carbamate

tert-butyl N-[2-oxo-2-(piperazin-1-yl)ethyl]carbamate

C11H21N3O3 (243.1583)


   

(4-BOC-PIPERAZIN-1-YL)-ACETAMIDE

(4-BOC-PIPERAZIN-1-YL)-ACETAMIDE

C11H21N3O3 (243.1583)


   

3-(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)PROPANOIC ACID

3-(1-(TERT-BUTOXYCARBONYL)PYRROLIDIN-3-YL)PROPANOIC ACID

C12H21NO4 (243.1471)


   

1-(2-DIMETHYLAMINOPROPYL)ADAMANTANEHYDROCHLORIDE

1-(2-DIMETHYLAMINOPROPYL)ADAMANTANEHYDROCHLORIDE

C14H26ClN (243.1754)


   

tert-butyl 2-(2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate

tert-butyl 2-(2-methoxy-2-oxoethyl)pyrrolidine-1-carboxylate

C12H21NO4 (243.1471)


   

4-(BOC-AMINO)CYCLOHEXANECARBOXYLIC ACID

4-(BOC-AMINO)CYCLOHEXANECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

S-METHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE

S-METHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE

C12H21NO4 (243.1471)


   

(2R,4S,5R)-TERT-BUTYL 5-(2-HYDROXYETHYL)-2-METHYLPIPERIDINE-4-CARBOXYLATE

(2R,4S,5R)-TERT-BUTYL 5-(2-HYDROXYETHYL)-2-METHYLPIPERIDINE-4-CARBOXYLATE

C13H25NO3 (243.1834)


   

1-Butyl-1-methylpiperidinium tetrafluoroborate

1-Butyl-1-methylpiperidinium tetrafluoroborate

C10H22BF4N (243.1781)


   

1-(4,4-diethoxybutyl)piperidin-2-one

1-(4,4-diethoxybutyl)piperidin-2-one

C13H25NO3 (243.1834)


   

tert-butyl 4-(2-oxoethoxy)piperidine-1-carboxylate

tert-butyl 4-(2-oxoethoxy)piperidine-1-carboxylate

C12H21NO4 (243.1471)


   

4-PIPERIDINEETHANOL TBS

4-PIPERIDINEETHANOL TBS

C13H29NOSi (243.2018)


   

(1S,3S)-N-BOC-1-AMINOCYCLOPENTANE-3-CARBOXYLIC ACID METHYL ESTER

(1S,3S)-N-BOC-1-AMINOCYCLOPENTANE-3-CARBOXYLIC ACID METHYL ESTER

C12H21NO4 (243.1471)


   

(2S)-2-HYDROXY-3-METHYL-N-[(2S)-1-{[(1S)-3-METHYL-2-OXO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-1-YL]AMINO}-1-OXOPROPAN-2-YL]BUTANAMIDE

(2S)-2-HYDROXY-3-METHYL-N-[(2S)-1-{[(1S)-3-METHYL-2-OXO-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPIN-1-YL]AMINO}-1-OXOPROPAN-2-YL]BUTANAMIDE

C12H21NO4 (243.1471)


   

3-cyclobutyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid

3-cyclobutyl-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid

C12H21NO4 (243.1471)


   

cis-3-{[(tert-butoxy)carbonyl]amino}cyclohexane-1-carboxylic acid

cis-3-{[(tert-butoxy)carbonyl]amino}cyclohexane-1-carboxylic acid

C12H21NO4 (243.1471)


   

α,α-Bis(trimethylsilyl)-tert-butylketimine

α,α-Bis(trimethylsilyl)-tert-butylketimine

C12H29NSi2 (243.1838)


   

(S)-2-BENZYL-2-N-BOCAMINO-ETHYLTHIOL

(S)-2-BENZYL-2-N-BOCAMINO-ETHYLTHIOL

C12H21NO4 (243.1471)


   

tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate

tert-butyl 3-(3-hydroxypropyl)piperidine-1-carboxylate

C13H25NO3 (243.1834)


   

tert-butyl 2-(3-hydroxypropyl)piperidine-1-carboxylate

tert-butyl 2-(3-hydroxypropyl)piperidine-1-carboxylate

C13H25NO3 (243.1834)


   

tert-Butyl 4-(2-hydroxyethyl)-4-methylpiperidine-1-carboxylate

tert-Butyl 4-(2-hydroxyethyl)-4-methylpiperidine-1-carboxylate

C13H25NO3 (243.1834)


   

tert-butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate

tert-butyl 3-(2-ethoxy-2-oxoethyl)azetidine-1-carboxylate

C12H21NO4 (243.1471)


   

tert-butyl 4-(methylcarbamoyl)piperazine-1-carboxylate

tert-butyl 4-(methylcarbamoyl)piperazine-1-carboxylate

C11H21N3O3 (243.1583)


   

N-butyladamantan-2-amine hydrochloride

N-butyladamantan-2-amine hydrochloride

C14H26ClN (243.1754)


   

Boc-L-Cyclopentylglycine

Boc-L-Cyclopentylglycine

C12H21NO4 (243.1471)


   

Ethyl 1-Boc-3-Pyrrolidinecarboxylate

Ethyl 1-Boc-3-Pyrrolidinecarboxylate

C12H21NO4 (243.1471)


   

N-Boc-1,4-Dioxa-8-aza-spiro[4.5]decane

N-Boc-1,4-Dioxa-8-aza-spiro[4.5]decane

C12H21NO4 (243.1471)


   

R-METHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE

R-METHYL 1-BOC-PIPERIDINE-2-CARBOXYLATE

C12H21NO4 (243.1471)


   

tert-Butyl 4-(3-hydroxypropyl)tetrahydro-1(2H)-pyridinecarboxylate

tert-Butyl 4-(3-hydroxypropyl)tetrahydro-1(2H)-pyridinecarboxylate

C13H25NO3 (243.1834)


   

(S)-tert-Butyl 2,2-dimethyl-4-(2-oxoethyl)oxazolidine-3-carboxylate

(S)-tert-Butyl 2,2-dimethyl-4-(2-oxoethyl)oxazolidine-3-carboxylate

C12H21NO4 (243.1471)


   

N-Boc-Piperidine-4-carboxylic acid methyl ester

N-Boc-Piperidine-4-carboxylic acid methyl ester

C12H21NO4 (243.1471)


   

1-Boc-4-piperidylacetic acid

1-Boc-4-piperidylacetic acid

C12H21NO4 (243.1471)


   

methyl 1-boc-piperidine-2-carboxylate

methyl 1-boc-piperidine-2-carboxylate

C12H21NO4 (243.1471)


   

TRIS(DIETYHYLAMIDO)ALUMINUM(III)

TRIS(DIETYHYLAMIDO)ALUMINUM(III)

(Al(N(C2H5)2)3) (243.2255)


   

1-Boc-2-Methylpiperidine-4-carboxylic Acid

1-Boc-2-Methylpiperidine-4-carboxylic Acid

C12H21NO4 (243.1471)


   

Boc-5,5-dimethyl-DL-Pro-OH

Boc-5,5-dimethyl-DL-Pro-OH

C12H21NO4 (243.1471)


   

TRANS-2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXANECARBOXYLIC ACID

TRANS-2-((TERT-BUTOXYCARBONYL)AMINO)CYCLOHEXANECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

(1R,3S)-3-BOC-AMINO-CYCLOHEXANECARBOXYLIC ACID

(1R,3S)-3-BOC-AMINO-CYCLOHEXANECARBOXYLIC ACID

C12H21NO4 (243.1471)


   

(S)-2-(tert-butoxycarbonylamino)-3-cyclobutylpropanoic acid

(S)-2-(tert-butoxycarbonylamino)-3-cyclobutylpropanoic acid

C12H21NO4 (243.1471)


   

(R)-2-(tert-butoxycarbonylamino)-3-cyclobutylpropanoic acid

(R)-2-(tert-butoxycarbonylamino)-3-cyclobutylpropanoic acid

C12H21NO4 (243.1471)


   

(S)-tert-Butyl (1-cyclohexyl-2-hydroxyethyl)carbamate

(S)-tert-Butyl (1-cyclohexyl-2-hydroxyethyl)carbamate

C13H25NO3 (243.1834)


   

tert-Butyl 4-(3-aminopropyl)piperazine-1-carboxylate

tert-Butyl 4-(3-aminopropyl)piperazine-1-carboxylate

C12H25N3O2 (243.1947)


   

Ethyl 4-(ethoxycarbonyl)piperidine-1-acetate

Ethyl 4-(ethoxycarbonyl)piperidine-1-acetate

C12H21NO4 (243.1471)


   

N-Boc-2-Piperidineacetic Acid

N-Boc-2-Piperidineacetic Acid

C12H21NO4 (243.1471)


   

1-Benzyl-4-(dimethylamino)piperidine-4-carbonitrile

1-Benzyl-4-(dimethylamino)piperidine-4-carbonitrile

C15H21N3 (243.1735)


   

(S)-TERT-BUTYL 4-(2-AMINOPROPYL)PIPERAZINE-1-CARBOXYLATE

(S)-TERT-BUTYL 4-(2-AMINOPROPYL)PIPERAZINE-1-CARBOXYLATE

C12H25N3O2 (243.1947)


   

Somantadine hydrochloride

Somantadine hydrochloride

C14H26ClN (243.1754)


C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

N-0861 racemate

N-0861 racemate

C13H17N5 (243.1484)


   

Amprolium ion

Amprolium ion

C14H19N4+ (243.161)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents

   

(2S,3R,4E)-2-Amino-4-tetradecene-1,3-diol

(2S,3R,4E)-2-Amino-4-tetradecene-1,3-diol

C14H29NO2 (243.2198)


   

2-Aminotetradecanoic acid

2-Aminotetradecanoic acid

C14H29NO2 (243.2198)


   

Cyclohexylmethyl-2,3-dihydroxy-5-methyl-hexylamide

Cyclohexylmethyl-2,3-dihydroxy-5-methyl-hexylamide

C14H29NO2 (243.2198)


   

Cyclohexyl-norstatine

Cyclohexyl-norstatine

C13H25NO3 (243.1834)


   

3-Methylbut-2-enoylcarnitine

3-[(3-methylbut-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C12H21NO4 (243.1471)


3-methylbut-2-enoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylbut-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-methylbut-2-enoylcarnitine is therefore classified as a short chain AC. As a short-chain acylcarnitine 3-methylbut-2-enoylcarnitine is a member of the most abundant group of carnitines in the body, comprising more than 50\\% of all acylcarnitines quantified in tissues and biofluids (PMID: 31920980). Some short-chain carnitines have been studied as supplements or treatments for a number of diseases, including neurological disorders and inborn errors of metabolism. Carnitine acetyltransferase (CrAT, EC:2.3.1.7) is responsible for the synthesis of all short-chain and short branched-chain acylcarnitines (PMID: 23485643). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxymorphinan

17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2,4,6-trien-4-ol

C16H21NO (243.1623)


D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids

   

3-Hydroxytetradecanoate

3-Hydroxytetradecanoate

C14H27O3- (243.196)


A 3-hydroxy fatty acid anion that is the conjugate base of 3-hydroxytetradecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

2-Hydroxymyristate

2-Hydroxymyristate

C14H27O3- (243.196)


A 2-hydroxy fatty acid anion that is the conjugate base of 2-hydroxymyristic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N3-dec-2-enoyl-N3-hydroxy-1,3-diaminopropane

N3-dec-2-enoyl-N3-hydroxy-1,3-diaminopropane

C13H27N2O2+ (243.2072)


   

2-Tiglylcarnitine

2-Tiglylcarnitine

C12H21NO4 (243.1471)


   

(3E)-Tiglylcarnitine

(3E)-Tiglylcarnitine

C12H21NO4 (243.1471)


   

(2S)-2-hydroxytetradecanoate

(2S)-2-hydroxytetradecanoate

C14H27O3- (243.196)


A (2S)-2-hydroxy fatty acid anion that is the conjugate base of (2S)-2-hydroxytetradecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

14-Hydroxymyristate

14-Hydroxymyristate

C14H27O3- (243.196)


A long-chain fatty acid anion that is the conjugate base of 14-hydroxymyristic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N-(2,3-dimethylphenyl)bicyclo[2.2.1]heptane-2-carboxamide

N-(2,3-dimethylphenyl)bicyclo[2.2.1]heptane-2-carboxamide

C16H21NO (243.1623)


   

(3R)-3-hydroxytetradecanoate

(3R)-3-hydroxytetradecanoate

C14H27O3- (243.196)


   

(2R)-2-hydroxytetradecanoate

(2R)-2-hydroxytetradecanoate

C14H27O3- (243.196)


A (2R)-2-hydroxy fatty acid anion that is the conjugate base of (2R)-2-hydroxytetradecanoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

2-Cyano-N,N-diethyl-2-(phenyl-hydrazono)-acetamidine

2-Cyano-N,N-diethyl-2-(phenyl-hydrazono)-acetamidine

C13H17N5 (243.1484)


   

9-Hydroxytetradecanoate

9-Hydroxytetradecanoate

C14H27O3- (243.196)


   

(S)-beta-Hydroxymyristate

(S)-beta-Hydroxymyristate

C14H27O3- (243.196)


   

6-(6-Aminohexanamido)hexanoate

6-(6-Aminohexanamido)hexanoate

C12H23N2O3- (243.1709)


   

13-Hydroxytetradecanoate

13-Hydroxytetradecanoate

C14H27O3- (243.196)


An (omega-1)-hydroxy fatty acid anion that is the conjugate base of 13-hydroxymyristic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

10-Hydroxytetradecanoate

10-Hydroxytetradecanoate

C14H27O3- (243.196)


   

11-Hydroxytetradecanoate

11-Hydroxytetradecanoate

C14H27O3- (243.196)


   

12-Hydroxytetradecanoate

12-Hydroxytetradecanoate

C14H27O3- (243.196)


   

N-(2,4-dimethylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide

N-(2,4-dimethylphenyl)-3-bicyclo[2.2.1]heptanecarboxamide

C16H21NO (243.1623)


   

N-(10-hydroxy-10-methylundecyl)acetamide

N-(10-hydroxy-10-methylundecyl)acetamide

C14H29NO2 (243.2198)


   

3-Dehydrotetradecasphinganine

3-Dehydrotetradecasphinganine

C14H29NO2 (243.2198)


   

7-Hydroxytetradecanoate

7-Hydroxytetradecanoate

C14H27O3- (243.196)


   

huperzine A(1+)

huperzine A(1+)

C15H19N2O+ (243.1497)


A primary ammonium ion that is the conjugate acid of huperzine A resulting from the protonation of the primary amino group; major species at pH 7.3.

   

(7S)-7-[propyl(prop-2-ynyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol

(7S)-7-[propyl(prop-2-ynyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol

C16H21NO (243.1623)


   

(S)-1-((S)-2,6-Diaminohexanoyl)pyrrolidine-2-carboxylic acid

(S)-1-((S)-2,6-Diaminohexanoyl)pyrrolidine-2-carboxylic acid

C11H21N3O3 (243.1583)


   

(E)-2-aminotetradec-4-ene-1,3-diol

(E)-2-aminotetradec-4-ene-1,3-diol

C14H29NO2 (243.2198)


   

6-Hydroxy-N-octylhexanamide

6-Hydroxy-N-octylhexanamide

C14H29NO2 (243.2198)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]butanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]butanamide

C13H25NO3 (243.1834)


   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]pentanamide

C13H25NO3 (243.1834)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]acetamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]acetamide

C13H25NO3 (243.1834)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]propanamide

C13H25NO3 (243.1834)


   

N-(1-Indanyl)-N-(2-butenyl)propanamide

N-(1-Indanyl)-N-(2-butenyl)propanamide

C16H21NO (243.1623)


   

N-Octyl(tert-butyldimethylsilyl)amine

N-Octyl(tert-butyldimethylsilyl)amine

C14H33NSi (243.2382)


   

3-Hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide

3-Hydroxy-N-[(3S)-tetrahydro-2-oxo-3-furanyl]-octanamide

C12H21NO4 (243.1471)


   

N-Undecanoylglycine

N-Undecanoylglycine

C13H25NO3 (243.1834)


An N-acylglycine with an acyl group that is undecanoyl.

   
   

O-Tiglyl-L-carnitine

O-Tiglyl-L-carnitine

C12H21NO4 (243.1471)


An O-acyl-L-carnitine compound having trans-2-methyl-2-butenoyl (tiglyl) as the acyl substituent.

   

2-ethylacryloylcarnitine

2-ethylacryloylcarnitine

C12H21NO4 (243.1471)


An O-acylcarnitine compound having 2-ethylacryloyl as the acyl substituent.

   

Tiglylcarnitine

Tiglylcarnitine

C12H21NO4 (243.1471)


   

(R)-3-Hydroxytetradecanoate

(R)-3-Hydroxytetradecanoate

C14H27O3 (243.196)


A (3R)-3-hydroxy fatty acid anion resulting from the deprotonation of the carboxy group of (3R)-3-hydroxytetradecanoic acid. The major species at pH 7.3.

   

O-Tiglylcarnitine

O-Tiglylcarnitine

C12H21NO4 (243.1471)


An O-acylcarnitine compound having trans-2-methyl-2-butenoyl (tiglyl) as the acyl substituent.

   

2-heptyl-4-quinolone

2-heptyl-4-quinolone

C16H21NO (243.1623)


A quinolone consisting of quinolin-4(1H)-one carrying a heptyl substituent at position 2.

   

AEA(12:0)

AEA(12:0)

C14H29NO2 (243.2198)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Heptylquinolone

Heptylquinolone

C16H21NO (243.1623)


   

Aminotetradecanoic acid

Aminotetradecanoic acid

C14H29NO2 (243.2198)


   
   
   
   
   
   
   

CAR 4:1(2Z);3Me

CAR 4:1(2Z);3Me

C12H21NO4 (243.1471)


   

Cer 8:1;O2/5:0

Cer 8:1;O2/5:0

C13H25NO3 (243.1834)


   

(2e,4e)-n-[(2s)-2-methylbutyl]undeca-2,4-dien-8,10-diynimidic acid

(2e,4e)-n-[(2s)-2-methylbutyl]undeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

(3-hydroxybutan-2-yl)[(1e)-3-(c-hydroxycarbonimidoyl)-3-propylprop-1-en-1-yl-oxo-λ⁵-azanylidene]amine

(3-hydroxybutan-2-yl)[(1e)-3-(c-hydroxycarbonimidoyl)-3-propylprop-1-en-1-yl-oxo-λ⁵-azanylidene]amine

C11H21N3O3 (243.1583)


   

3-hydroxy-n-(2-oxooxolan-3-yl)octanimidic acid

3-hydroxy-n-(2-oxooxolan-3-yl)octanimidic acid

C12H21NO4 (243.1471)


   

n-(3-hydroxydodecan-2-yl)ethanimidic acid

n-(3-hydroxydodecan-2-yl)ethanimidic acid

C14H29NO2 (243.2198)


   

(2r,3r,7z)-2-aminotetradec-7-ene-1,3-diol

(2r,3r,7z)-2-aminotetradec-7-ene-1,3-diol

C14H29NO2 (243.2198)


   

(2e,4z)-n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

(2e,4z)-n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

n-[(2r,3s)-3-hydroxydodecan-2-yl]ethanimidic acid

n-[(2r,3s)-3-hydroxydodecan-2-yl]ethanimidic acid

C14H29NO2 (243.2198)


   

2-aminotetradec-4-ene-1,3-diol

2-aminotetradec-4-ene-1,3-diol

C14H29NO2 (243.2198)


   

(3-hydroxybutan-2-yl)[3-(c-hydroxycarbonimidoyl)-3-propylprop-1-en-1-yl-oxo-λ⁵-azanylidene]amine

(3-hydroxybutan-2-yl)[3-(c-hydroxycarbonimidoyl)-3-propylprop-1-en-1-yl-oxo-λ⁵-azanylidene]amine

C11H21N3O3 (243.1583)


   

(2e,4z)-n-(2-phenylethyl)octa-2,4-dienimidic acid

(2e,4z)-n-(2-phenylethyl)octa-2,4-dienimidic acid

C16H21NO (243.1623)


   

4-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}butan-1-amine

4-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl}butan-1-amine

C15H21N3 (243.1735)


   

(2r,3r,4s)-3-methyl-2-[(1e,3e)-4-phenylbuta-1,3-dien-1-yl]piperidin-4-ol

(2r,3r,4s)-3-methyl-2-[(1e,3e)-4-phenylbuta-1,3-dien-1-yl]piperidin-4-ol

C16H21NO (243.1623)


   

tetradecasphingosine

tetradecasphingosine

C14H29NO2 (243.2198)


   

(3s)-3-hydroxy-n-[(3s)-2-oxooxolan-3-yl]octanimidic acid

(3s)-3-hydroxy-n-[(3s)-2-oxooxolan-3-yl]octanimidic acid

C12H21NO4 (243.1471)


   

(2r,3s)-2-aminododecan-3-yl acetate

(2r,3s)-2-aminododecan-3-yl acetate

C14H29NO2 (243.2198)


   

2-aminododecan-3-yl acetate

2-aminododecan-3-yl acetate

C14H29NO2 (243.2198)


   

n-(2-phenylethyl)octa-2,4-dienimidic acid

n-(2-phenylethyl)octa-2,4-dienimidic acid

C16H21NO (243.1623)


   

(3s,7r)-7-hexyl-5-hydroxy-3-(hydroxymethyl)-6,7-dihydro-3h-1,4-oxazepin-2-one

(3s,7r)-7-hexyl-5-hydroxy-3-(hydroxymethyl)-6,7-dihydro-3h-1,4-oxazepin-2-one

C12H21NO4 (243.1471)


   

7-hexyl-5-hydroxy-3-(hydroxymethyl)-6,7-dihydro-3h-1,4-oxazepin-2-one

7-hexyl-5-hydroxy-3-(hydroxymethyl)-6,7-dihydro-3h-1,4-oxazepin-2-one

C12H21NO4 (243.1471)


   

(2z,4e)-n-(2-phenylethyl)octa-2,4-dienimidic acid

(2z,4e)-n-(2-phenylethyl)octa-2,4-dienimidic acid

C16H21NO (243.1623)


   

2-aminotetradec-7-ene-1,3-diol

2-aminotetradec-7-ene-1,3-diol

C14H29NO2 (243.2198)


   

n-(2-methylbutyl)undeca-2,4-dien-8,10-diynimidic acid

n-(2-methylbutyl)undeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

(6e,8e)-9-(7-methyl-7h-azepin-2-yl)nona-6,8-dien-3-one

(6e,8e)-9-(7-methyl-7h-azepin-2-yl)nona-6,8-dien-3-one

C16H21NO (243.1623)


   

(2e)-n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

(2e)-n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

(2e,4e)-n-(2-methylbutyl)undeca-2,4-dien-8,10-diynimidic acid

(2e,4e)-n-(2-methylbutyl)undeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

(2e,4z)-n-[(2s)-2-methylbutyl]undeca-2,4-dien-8,10-diynimidic acid

(2e,4z)-n-[(2s)-2-methylbutyl]undeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

(2e,4z)-n-(2-methylbutyl)undeca-2,4-dien-8,10-diynimidic acid

(2e,4z)-n-(2-methylbutyl)undeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

(2s,3r)-2-aminotetradec-4-ene-1,3-diol

(2s,3r)-2-aminotetradec-4-ene-1,3-diol

C14H29NO2 (243.2198)


   

(2r,3s,4e)-2-aminotetradec-4-ene-1,3-diol

(2r,3s,4e)-2-aminotetradec-4-ene-1,3-diol

C14H29NO2 (243.2198)


   

(2z,4e)-n-(2-methylbutyl)undeca-2,4-dien-8,10-diynimidic acid

(2z,4e)-n-(2-methylbutyl)undeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

(2r)-6-hydroxy-2-[(4r)-2-iminoimidazolidin-4-yl]-6-methylheptanoic acid

(2r)-6-hydroxy-2-[(4r)-2-iminoimidazolidin-4-yl]-6-methylheptanoic acid

C11H21N3O3 (243.1583)


   

(2e,4e)-n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

(2e,4e)-n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)


   

(2z,4e)-n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

(2z,4e)-n-(2-methylpropyl)dodeca-2,4-dien-8,10-diynimidic acid

C16H21NO (243.1623)